Endocrine Testing Market Set for Robust Expansion - Persistence Market Research Sees US$ 23.2 Bn by 2032

The global endocrine testing market has experienced remarkable growth in recent years, driven by increasing awareness about hormone-related disorders, advancements in diagnostic technologies, and rising healthcare investments. As we move forward into the next decade, the market is expected to continue its expansion trajectory, offering new opportunities for innovation, access, and treatment solutions. According to a report by Persistence Market Research, the endocrine testing market size is projected to reach US$ 13.4 billion in 2025 and is expected to grow at a compound annual growth rate (CAGR) of 8.2%, reaching a market value of US$ 23.2 billion by 2032.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35201

Overview of the Endocrine Testing Market

Endocrine testing involves a series of medical diagnostic tests used to measure hormone levels and diagnose various disorders of the endocrine system. These tests help detect imbalances in hormones such as thyroid-stimulating hormone (TSH), insulin, cortisol, and others. With increasing cases of hormone-related conditions, such as diabetes, thyroid disorders, and adrenal insufficiency, the demand for endocrine testing is growing rapidly. Moreover, the market has been further spurred by innovations in testing technologies, including automation and multiplex assays, as well as the increasing availability of home testing kits.

Market Statistics

The global endocrine testing market was valued at approximately US$ 13.4 billion in 2025, with projections indicating it will reach US$ 23.2 billion by 2032. This growth reflects a robust CAGR of 8.2%, driven by factors such as improved awareness, rising prevalence of endocrine disorders, and technological advancements. Additionally, the historical growth rate between 2019 and 2024 was 7.4%, further showcasing the sector's steady expansion.

Key Growth Drivers

Several factors are contributing to the rapid growth of the endocrine testing market. First and foremost, there is an increasing prevalence of chronic conditions such as diabetes, obesity, thyroid dysfunction, and metabolic syndrome, which require regular monitoring and diagnostic testing. The global rise in lifestyle-related diseases and aging populations further accelerates the demand for hormone testing.

Additionally, advancements in diagnostic technologies have played a pivotal role in shaping market trends. The introduction of more precise, automated diagnostic tools and the growth of point-of-care (POC) testing solutions have made it easier to diagnose endocrine disorders. These developments ensure that tests are more efficient, cost-effective, and accurate, facilitating their widespread adoption.

Leading Segment and Leading Geographical Region

Thyroid Stimulating Hormone (TSH) testing is one of the leading segments within the endocrine testing market, expected to account for a significant market share of 29.4% by 2025. This is primarily due to the rising incidence of thyroid disorders worldwide and the increasing focus on early diagnosis. Moreover, North America is projected to hold the largest share of the market during the forecast period, driven by a high prevalence of thyroid cancer, diabetes, and other hormone-related diseases, coupled with advancements in diagnostic technologies.

Key Highlights from the Report

➤ The endocrine testing market size is expected to reach US$ 13.4 billion by 2025, with a forecasted value of US$ 23.2 billion by 2032.
➤ The market is witnessing significant growth, driven by the increasing prevalence of diabetes, thyroid disorders, and adrenal insufficiencies.
➤ Innovations in testing technologies, such as mass spectrometry and multiplex assays, are boosting market efficiency.
➤ Point-of-care and home-based endocrine testing kits are gaining popularity, making testing more accessible.
➤ Awareness campaigns and public health initiatives are driving routine screening for endocrine disorders.
➤ Rising healthcare infrastructure investments in emerging markets are contributing to market growth.

Market Segmentation

The endocrine testing market is diverse, with multiple categories based on product type, technology, and end-user. Understanding these segments allows healthcare providers and diagnostic companies to target specific needs more effectively.

By Product Type

The market is segmented into various product categories, including thyroid function tests, adrenal tests, reproductive hormone tests, and others. Thyroid function tests, particularly TSH tests, dominate the market due to the increasing prevalence of thyroid disorders. In addition, reproductive hormone testing, particularly for conditions like polycystic syndrome (PCOS), is expected to grow as awareness surrounding hormonal health improves.

By Technology

Key technological advancements such as mass spectrometry (MS/MS) and immunoassays have significantly impacted the endocrine testing market. Tandem mass spectrometry, in particular, is gaining traction for its ability to detect multiple hormones simultaneously, offering improved accuracy and efficiency in diagnosing endocrine disorders. This technology is especially useful for monitoring conditions like adrenal insufficiency and congenital adrenal hyperplasia.

✅Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/endocrine-testing-market.asp

Regional Insights

North America

North America leads the global endocrine testing market, largely due to the high prevalence of hormone-related diseases such as diabetes and thyroid disorders. Additionally, the region benefits from advanced healthcare infrastructure, a high rate of awareness, and early diagnosis campaigns. Innovations in diagnostic technologies, along with an increasing demand for point-of-care testing solutions, further support market expansion.

Europe

Europe's market is being driven by rising obesity rates and a growing focus on preventive healthcare. Obesity-related conditions, such as diabetes and thyroid disorders, have spurred the demand for endocrine testing services in countries across Europe. Increased health awareness and the widespread adoption of routine endocrine screenings are expected to continue driving market growth.

Market Drivers

One of the primary drivers for the growth of the endocrine testing market is the increasing awareness of hormone-related disorders and the growing emphasis on early diagnosis. Conditions such as diabetes, thyroid dysfunction, and adrenal disorders have become increasingly common, leading to a surge in the demand for endocrine tests. Public health campaigns and advancements in home-based testing solutions have contributed to the widespread acceptance of these diagnostic tests.

Another important factor is the aging global population. As people age, they are more likely to experience hormonal imbalances and conditions such as hypothyroidism or adrenal insufficiency, which necessitate regular monitoring through endocrine testing.

Market Restraints

Despite the promising market growth, several challenges exist. The primary restraint is the high cost associated with endocrine testing, particularly with advanced diagnostic technologies that require specialized equipment and highly trained professionals. The affordability issue is particularly prevalent in low- and middle-income countries, where access to healthcare infrastructure remains limited.

Additionally, regulatory hurdles and reimbursement challenges in some regions could slow down the adoption of endocrine testing. These barriers are significant in areas with less-developed healthcare systems or where insurance coverage is limited.

Market Opportunities

The increasing global prevalence of endocrine-related disorders presents an immense opportunity for market growth. The demand for tests like TSH and diabetes-related assays is expected to continue rising, offering lucrative prospects for companies operating in this space. The shift towards preventive healthcare and the growing popularity of home-based diagnostic tests are two key opportunities.

Advancements in personalized medicine are also contributing to market opportunities. Hormone-based testing, combined with personalized healthcare approaches, can provide tailored treatments that improve patient outcomes and drive the adoption of endocrine tests.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/35201

Reasons to Buy the Report

✔ Gain in-depth insights into the global endocrine testing market, including trends, growth drivers, and challenges.
✔ Understand regional market dynamics and the factors influencing demand across various regions.
✔ Explore the competitive landscape and identify key players, strategies, and recent market developments.
✔ Discover emerging opportunities in the endocrine testing market, especially in home-based and point-of-care testing solutions.
✔ Access detailed market forecasts and segment-wise analysis to help make informed business decisions.

Company Insights

Several key players are operating in the global endocrine testing market. These companies focus on developing innovative testing solutions, partnerships with healthcare providers, and expanding their product portfolios to stay competitive.

Key Players in the Market:
✦ Abbott Laboratories, Inc.
✦ AB Sciex Pte. Ltd.
✦ Agilent Technologies, Inc.
✦ bioMérieux SA
✦ Bio-Rad Laboratories Inc.
✦ DiaSorin S.p.A.
✦ F. Hoffmann-La Roche Ltd.
✦ Laboratory Corporation of America Holdings (LabCorp)
✦ Quest Diagnostics, Inc.
✦ Thermo Fisher Scientific, Inc.
✦ MP Biomedicals
✦ Ortho-Clinical Diagnostics (QuidelOrtho Corporation)
✦ Siemens Healthineers AG
✦ Sysmex Corporation

Recent Developments:

In March 2025, London-based HealthTech startup Level Zero Health secured US$ 8.4 million in pre-seed funding to advance remote and continuous hormone monitoring using DNA-based sensor technology.

In January 2025, Eli Health launched the Hormometer at CES, an AI-powered, saliva-based hormone testing kit that allows real-time, at-home multi-hormone analysis.

The global endocrine testing market is poised for continued growth, driven by advancements in diagnostic technology, increasing health awareness, and the rising prevalence of hormone-related disorders. As the industry evolves, companies will continue to innovate, making endocrine testing more accessible, accurate, and cost-effective for patients worldwide.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.